Seems to me that reclassifying MJ from a schedule 1 drug would be great for the overall MJ movement but I am not so sure it would be that great of a thing for the current MJ companies.
I see it as more of a double edged sword for PHOT and many of the other MJ companies.
Initially I believe it would provide a bump/spike for any of the companies in the sector.
At the same time it would open the flood gates for all of the big money investors and companies (tobacco, pharmaceuticals, etc.) that currently won’t touch the sector because it is a schedule 1 and federally illegal.
At that point the game changes drastically. Some might think that the current companies would be bought out by the big money folks but that is not necessarily true. Most of these companies are highly diluted and overpriced. It would be simpler to just start up their own companies and bury many of the current companies.
Some will say that the PHOT and FITX would be a great buy as they have the inside track to Canada. Keep in mind FITX has not been licensed yet while there are at least 5 established companies that I know of that have already been approved and are producing MJ as I type. I am sure there will be more licenses granted to companies and they won’t have 7B A/S’s of which approximately 5B are issued.
We act as though we are in a vacuum and there are no other companies with far more money and much better connections politically and business wise that will step in a heartbeat.
After watching what some of these fly by night shells have accomplished and how much they have made it is foolish to think more established companies will not take over the sector. JMHO.
Careful what you wish for. Have to think about that a little more.